Title:
SSAO INHIBITORS AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2021/083209
Kind Code:
A1
Abstract:
Provided are a compound of formula (I') or (I), a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of SSAO, a pharmaceutical composition comprising a compound of formula (I') or (I), and a method of treating or preventing a disease in which SSAO plays a role.
More Like This:
Inventors:
REN ZAIFANG (CN)
SUN XUEFENG (CN)
XU QING (CN)
SUN XUEFENG (CN)
XU QING (CN)
Application Number:
PCT/CN2020/124381
Publication Date:
May 06, 2021
Filing Date:
October 28, 2020
Export Citation:
Assignee:
ECCOGENE SHANGHAI CO LTD (CN)
International Classes:
C07D309/04; A61K31/10; A61P3/00; A61P9/00; A61P29/00; C07C317/14; C07D205/04; C07D207/06; C07D211/46; C07D275/02; C07D295/08; C07D307/10; C07D309/06; C07D309/08; C07D309/10; C07D309/12; C07D319/12; C07D401/04
Domestic Patent References:
WO2019024924A1 | 2019-02-07 | |||
WO2007120528A2 | 2007-10-25 | |||
WO2013163675A1 | 2013-11-07 | |||
WO2019241751A1 | 2019-12-19 | |||
WO2020086747A2 | 2020-04-30 |
Other References:
See also references of EP 4051669A4
Attorney, Agent or Firm:
LIU, SHEN & ASSOCIATES (CN)
Download PDF:
Previous Patent: NETWORK TOPOLOGY DISCOVERY METHOD AND NODE DEVICE
Next Patent: SYSTEM AND METHOD FOR HYBRID-ARQ
Next Patent: SYSTEM AND METHOD FOR HYBRID-ARQ